Silence Therapeutics plc (SLN) /
The debt of Silence Therapeutics plc over the past 4 years
Chart Silence Therapeutics plc: liquid cash, total debt, net cash, fiscal 2022–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Silence Therapeutics plc had liquid cash of $85.11M and total debt of $0: net cash of $85.11M. It had more liquid cash than debt at all 3 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $85.11M* | $0 | $85.11M |
| 2024ended Dec 31, 2024 | $147.33M* | $0 | $147.33M |
| 2023ended Dec 31, 2023 | $68.79M | $0 | $68.79M |
| 2022ended Dec 31, 2022 | — | — | — |
Fiscal years as Silence Therapeutics plc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Silence Therapeutics plc
- The revenue of Silence Therapeutics plc
- The profitability of Silence Therapeutics plc
- The cash flow of Silence Therapeutics plc
- All of Silence Therapeutics plc's financials, charted
Companies of a similar size
- GRBKGreen Brick Partners, Inc.
- ASANAsana, Inc.
- CWKCushman & Wakefield Ltd.
- FBKFB FINANCIAL CORPORATION
- BTUPEABODY ENERGY CORP
Not investment advice. This page shows what Silence Therapeutics plc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.